ReP USP - Resultado da busca

Artigo de periodico
Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation (2022)
Colella, Marcos Paulo ; Morini, Beatriz Corey; Niemann, Fernanda Soares ; Lopes, Matheus Rodrigues ; Vigorito, Afonso Celso ; Aranha, Francisco José Penteado; Machado Neto, João Agostinho ; Saad, Sara Olalla ; Favaro, Patricia
Fonte: Transplant Immunology. Unidade: ICB
Assuntos: FARMACOLOGIA, CÉLULAS-TRONCO, TRANSPLANTES, CÉLULAS SANGUÍNEAS, FATORES DE CRESCIMENTO, TECIDO CONJUNTIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COLELLA, Marcos Paulo et al. Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Transplant Immunology, v. 70, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.trim.2021.101514. Acesso em: 25 out. 2025.
APA
Colella, M. P., Morini, B. C., Niemann, F. S., Lopes, M. R., Vigorito, A. C., Aranha, F. J. P., et al. (2022). Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Transplant Immunology, 70, 1-11. doi:10.1016/j.trim.2021.101514
NLM
Colella MP, Morini BC, Niemann FS, Lopes MR, Vigorito AC, Aranha FJP, Machado Neto JA, Saad SO, Favaro P. Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation [Internet]. Transplant Immunology. 2022 ; 70 1-11.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.trim.2021.101514
Vancouver
Colella MP, Morini BC, Niemann FS, Lopes MR, Vigorito AC, Aranha FJP, Machado Neto JA, Saad SO, Favaro P. Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation [Internet]. Transplant Immunology. 2022 ; 70 1-11.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.trim.2021.101514
Artigo de periodico
De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes (2017)
Lopes, Matheus Rodrigues; Pereira, João Kleber Novais; Campos, Paula de Melo; Machado Neto, João Agostinho ; Traina, Fabiola; Saad, Sara Teresinha Olalla; Favaro, Patricia
Fonte: Scientific Reports. Unidades: ICB, FMRP
Assuntos: MEDULA ÓSSEA, PROLIFERAÇÃO CELULAR, QUIMIOTAXIA, CITOCINAS, LEUCEMIA MIELOIDE AGUDA, MICRORNAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. Scientific Reports, v. 7, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1038/srep40707. Acesso em: 25 out. 2025.
APA
Lopes, M. R., Pereira, J. K. N., Campos, P. de M., Machado Neto, J. A., Traina, F., Saad, S. T. O., & Favaro, P. (2017). De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. Scientific Reports, 7( 1). doi:10.1038/srep40707
NLM
Lopes MR, Pereira JKN, Campos P de M, Machado Neto JA, Traina F, Saad STO, Favaro P. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2025 out. 25 ] Available from: https://doi.org/10.1038/srep40707
Vancouver
Lopes MR, Pereira JKN, Campos P de M, Machado Neto JA, Traina F, Saad STO, Favaro P. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2025 out. 25 ] Available from: https://doi.org/10.1038/srep40707
Artigo de periodico
IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients (2017)
Lopes, Matheus Rodrigues; Pereira, João Kleber Novais; Traina, Fabiola; Campos, Paula de Melo; Machado Neto, João Agostinho ; Saad, Sara Teresinha Olalla; Favaro, Patricia
Fonte: Applied Cancer Research. Unidade: FMRP
Assuntos: LEUCEMIA MIELOIDE, IMUNOLOGIA, INTERLEUCINAS, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients. Applied Cancer Research, v. 37, p. 6 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s41241-017-0017-9. Acesso em: 25 out. 2025.
APA
Lopes, M. R., Pereira, J. K. N., Traina, F., Campos, P. de M., Machado Neto, J. A., Saad, S. T. O., & Favaro, P. (2017). IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients. Applied Cancer Research, 37, 6 . doi:10.1186/s41241-017-0017-9
NLM
Lopes MR, Pereira JKN, Traina F, Campos P de M, Machado Neto JA, Saad STO, Favaro P. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients [Internet]. Applied Cancer Research. 2017 ; 37 6 .[citado 2025 out. 25 ] Available from: https://doi.org/10.1186/s41241-017-0017-9
Vancouver
Lopes MR, Pereira JKN, Traina F, Campos P de M, Machado Neto JA, Saad STO, Favaro P. IL32 expression in peripheral blood CD3+ cells from myelodysplastic syndromes patients [Internet]. Applied Cancer Research. 2017 ; 37 6 .[citado 2025 out. 25 ] Available from: https://doi.org/10.1186/s41241-017-0017-9
Artigo de periodico
Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia (2015)
Pereira, João Kleber Novais; Machado Neto, João Agostinho ; Lopes, Matheus Rodrigues; Morini, Beatriz Corey; Traina, Fabíola; Costa, Fernando Ferreira; Saad, Sara Teresinha Olalla; Favaro, Patricia
Fonte: European Journal of Cancer. Unidade: FMRP
Assuntos: LEUCEMIA, LINFOMA, LINHAGEM CELULAR, FÁRMACOS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, João Kleber Novais et al. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia. European Journal of Cancer, v. 51, n. 14, p. 2076–2085, 2015Tradução . . Disponível em: https://doi.org/10.1016/j.ejca.2015.07.018. Acesso em: 25 out. 2025.
APA
Pereira, J. K. N., Machado Neto, J. A., Lopes, M. R., Morini, B. C., Traina, F., Costa, F. F., et al. (2015). Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia. European Journal of Cancer, 51( 14), 2076–2085. doi:10.1016/j.ejca.2015.07.018
NLM
Pereira JKN, Machado Neto JA, Lopes MR, Morini BC, Traina F, Costa FF, Saad STO, Favaro P. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia [Internet]. European Journal of Cancer. 2015 ; 51( 14): 2076–2085.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2015.07.018
Vancouver
Pereira JKN, Machado Neto JA, Lopes MR, Morini BC, Traina F, Costa FF, Saad STO, Favaro P. Molecular effects of the phosphatidylinositol-3-kinase inhibitor NVP-BKM120 on T and B-cell acute lymphoblastic leukaemia [Internet]. European Journal of Cancer. 2015 ; 51( 14): 2076–2085.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.ejca.2015.07.018
Artigo de periodico
Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion (2014)
Roversi, Fernanda Marconi; Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Longhini, Ana Leda F.; Duarte, Adriana Silva Santos; Baratti, Mariana O.; Palodetto, Bruna; Corrocher, Flávia Adolfo; Pericole, Fernando V.; Campos, Paula de Melo; Favaro, Patricia; Traina, Fabíola; Saad, Sara Teresinha Olalla
Fonte: Stem Cells and Development. Unidade: FMRP
Assuntos: DOENÇAS HEMATOLÓGICAS, HEMATOPOESE, INIBIDORES DE ENZIMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVERSI, Fernanda Marconi et al. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion. Stem Cells and Development, v. 23, n. 10, p. 1109-1120, 2014Tradução . . Disponível em: https://doi.org/10.1089/scd.2013.0441. Acesso em: 25 out. 2025.
APA
Roversi, F. M., Lopes, M. R., Machado Neto, J. A., Longhini, A. L. F., Duarte, A. S. S., Baratti, M. O., et al. (2014). Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion. Stem Cells and Development, 23( 10), 1109-1120. doi:10.1089/scd.2013.0441
NLM
Roversi FM, Lopes MR, Machado Neto JA, Longhini ALF, Duarte ASS, Baratti MO, Palodetto B, Corrocher FA, Pericole FV, Campos P de M, Favaro P, Traina F, Saad STO. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion [Internet]. Stem Cells and Development. 2014 ; 23( 10): 1109-1120.[citado 2025 out. 25 ] Available from: https://doi.org/10.1089/scd.2013.0441
Vancouver
Roversi FM, Lopes MR, Machado Neto JA, Longhini ALF, Duarte ASS, Baratti MO, Palodetto B, Corrocher FA, Pericole FV, Campos P de M, Favaro P, Traina F, Saad STO. Serine protease inhibitor kunitz-type 2 is downregulated in myelodysplastic syndromes and modulates cell–cell adhesion [Internet]. Stem Cells and Development. 2014 ; 23( 10): 1109-1120.[citado 2025 out. 25 ] Available from: https://doi.org/10.1089/scd.2013.0441
Trabalho de evento-resumo
FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation (2013)
Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Traina, Fabíola; Pereira, João Kleber Novais; Lorand-Metze, Irene; Costa, Fernando Ferreira; Saad, Sara Teresinha Ollala; Favaro, Patricia
Fonte: Abstracts, Program and Personal Scheduler. Nome do evento: Annual Meeting and Exposition of American Society of Hematology (ASH). Unidade: FMRP
Assuntos: DOENÇAS HEMATOLÓGICAS, HEMATOPOESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper60188.html. Acesso em: 25 out. 2025.
APA
Lopes, M. R., Machado Neto, J. A., Traina, F., Pereira, J. K. N., Lorand-Metze, I., Costa, F. F., et al. (2013). FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper60188.html
NLM
Lopes MR, Machado Neto JA, Traina F, Pereira JKN, Lorand-Metze I, Costa FF, Saad STO, Favaro P. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2025 out. 25 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper60188.html
Vancouver
Lopes MR, Machado Neto JA, Traina F, Pereira JKN, Lorand-Metze I, Costa FF, Saad STO, Favaro P. FMNL1 is downregulated in myelodysplastic syndromes and is involved in megakaryocytic differentiation [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2025 out. 25 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper60188.html
Trabalho de evento-resumo
Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression (2013)
Roversi, Fernanda Marconi; Lopes, Matheus Rodrigues; Machado Neto, João Agostinho ; Longhini, Ana Leda; Duarte, Adriana Silva Santos; Palodetto, Bruna; Corrocher, Flavia Adolfo; Campos, Paula de Melo; Baratti, Mariana O.; Pericole, Fernando V.; Favaro, Patricia; Traina, Fabíola; Saad, Sara Teresinha Ollala
Fonte: Abstracts, Program and Personal Scheduler. Nome do evento: Annual Meeting and Exposition of American Society of Hematology (ASH). Unidade: FMRP
Assuntos: HEMATOPOESE, DOENÇAS HEMATOLÓGICAS, GENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ROVERSI, Fernanda Marconi et al. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression. 2013, Anais.. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2013. Disponível em: https://ash.confex.com/ash/2013/webprogram/Paper57527.html. Acesso em: 25 out. 2025.
APA
Roversi, F. M., Lopes, M. R., Machado Neto, J. A., Longhini, A. L., Duarte, A. S. S., Palodetto, B., et al. (2013). Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression. In Abstracts, Program and Personal Scheduler. New Orleans: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Recuperado de https://ash.confex.com/ash/2013/webprogram/Paper57527.html
NLM
Roversi FM, Lopes MR, Machado Neto JA, Longhini AL, Duarte ASS, Palodetto B, Corrocher FA, Campos P de M, Baratti MO, Pericole FV, Favaro P, Traina F, Saad STO. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2025 out. 25 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper57527.html
Vancouver
Roversi FM, Lopes MR, Machado Neto JA, Longhini AL, Duarte ASS, Palodetto B, Corrocher FA, Campos P de M, Baratti MO, Pericole FV, Favaro P, Traina F, Saad STO. Downregulation of SPINT2 expression in stromal cells from myelodysplastic syndrome patients increases HGF and SDF-1 secretion and promotes cell-cell adhesion by alteration in integrin expression [Internet]. Abstracts, Program and Personal Scheduler. 2013 ;[citado 2025 out. 25 ] Available from: https://ash.confex.com/ash/2013/webprogram/Paper57527.html
Artigo de periodico
FMNL1 promotes proliferation and migration of leukemia cells (2013)
Favaro, Patricia; Traina, Fabiola; Machado Neto, João Agostinho ; Lazarini, Mariana; Lopes, Matheus Rodrigues; Pereira, João Kleber Novais; Costa, Fernando Ferreira; Infante, Elvira; Ridley, Anne J.; Saad, Sara Teresinha Ollala
Fonte: Journal of Leukocyte Biology. Unidade: FMRP
Assuntos: LEUCEMIA, APOPTOSE, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FAVARO, Patricia et al. FMNL1 promotes proliferation and migration of leukemia cells. Journal of Leukocyte Biology, v. 94, n. 3, p. 503-512, 2013Tradução . . Disponível em: https://doi.org/10.1189/jlb.0113057. Acesso em: 25 out. 2025.
APA
Favaro, P., Traina, F., Machado Neto, J. A., Lazarini, M., Lopes, M. R., Pereira, J. K. N., et al. (2013). FMNL1 promotes proliferation and migration of leukemia cells. Journal of Leukocyte Biology, 94( 3), 503-512. doi:10.1189/jlb.0113057
NLM
Favaro P, Traina F, Machado Neto JA, Lazarini M, Lopes MR, Pereira JKN, Costa FF, Infante E, Ridley AJ, Saad STO. FMNL1 promotes proliferation and migration of leukemia cells [Internet]. Journal of Leukocyte Biology. 2013 ; 94( 3): 503-512.[citado 2025 out. 25 ] Available from: https://doi.org/10.1189/jlb.0113057
Vancouver
Favaro P, Traina F, Machado Neto JA, Lazarini M, Lopes MR, Pereira JKN, Costa FF, Infante E, Ridley AJ, Saad STO. FMNL1 promotes proliferation and migration of leukemia cells [Internet]. Journal of Leukocyte Biology. 2013 ; 94( 3): 503-512.[citado 2025 out. 25 ] Available from: https://doi.org/10.1189/jlb.0113057
Artigo de periodico
IL10 inversely correlates with the percentage of CD8+ cells in MDS patients (2013)
Lopes, Matheus Rodrigues; Traina, Fabiola; Campos, Paula de Melo; Pereira, João Kleber Novais; Machado Neto, João Agostinho ; Machado, Helymar da Costa; Gilli, Simone Cristina Olenscki; Saad, Sara Teresinha Olalla; Favaro, Patricia
Fonte: Leukemia Research. Unidade: FMRP
Assuntos: IDOSOS, DOENÇAS HEMATOLÓGICAS, REGULAÇÃO GÊNICA, LINFÓCITOS T
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOPES, Matheus Rodrigues et al. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research, v. 37, n. 5, p. 541-546, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2013.01.019. Acesso em: 25 out. 2025.
APA
Lopes, M. R., Traina, F., Campos, P. de M., Pereira, J. K. N., Machado Neto, J. A., Machado, H. da C., et al. (2013). IL10 inversely correlates with the percentage of CD8+ cells in MDS patients. Leukemia Research, 37( 5), 541-546. doi:10.1016/j.leukres.2013.01.019
NLM
Lopes MR, Traina F, Campos P de M, Pereira JKN, Machado Neto JA, Machado H da C, Gilli SCO, Saad STO, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients [Internet]. Leukemia Research. 2013 ; 37( 5): 541-546.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.leukres.2013.01.019
Vancouver
Lopes MR, Traina F, Campos P de M, Pereira JKN, Machado Neto JA, Machado H da C, Gilli SCO, Saad STO, Favaro P. IL10 inversely correlates with the percentage of CD8+ cells in MDS patients [Internet]. Leukemia Research. 2013 ; 37( 5): 541-546.[citado 2025 out. 25 ] Available from: https://doi.org/10.1016/j.leukres.2013.01.019

Unidades USP

ReP

Filtros

Autores

Assuntos

Título da fonte

Indexado em

Afiliação dos autores externos não normalizada